Manipal Health Enterprises shines on debut

Shares of Manipal Health Enterprises were currently trading at Rs 650.50 at 10:15 IST on the BSE, representing a premium of 10.25% as compared with the issue price of Rs 590.

The stock debuted at Rs 655, marking a premium of 11.02% to the issue price.

So far, the stock has hit a high of Rs 660 and a low of Rs 634.55. On the BSE, over 26.91 lakh shares of the company were traded in the counter so far.

The initial public offer of Manipal Health Enterprises was subscribed 4.92 times. The issue opened for bidding on 29 July 2026 and it closed on 31 July 2026. The price band of the IPO is fixed between Rs 560 and 590 per share.

The IPO comprised a fresh issue of equity shares aggregating up to Rs 8,000 crore and an offer for sale of 2,16,13,834 equity shares aggregating up to Rs 1,275.22 crore by existing shareholders, including Imperius Healthcare Investments, Manipal Education and Medical Group India, TPG SG Magazine and Seventy Second Investment Company LLC, among others.

The objectives of the fresh issue included Rs 5,552.75 crore for the repayment/prepayment of certain outstanding borrowings, Rs 574 crore for the acquisition of a minority stake in its step-down subsidiary, Sahyadri Hospitals, and the remaining amount was allocated for general corporate purposes.

The promoters, including Dr. Ranjan Ramdas Pai and Manipal Global Health Services, held 81.86% of the pre-IPO equity share capital, which declined to around 72.09% post-IPO.

Manipal Health Enterprises is one of India's leading healthcare service providers, operating 49 multi-specialty hospitals with 13,037 licensed beds across 14 states and union territories as of 31 March 2026. Backed by the Manipal Group, the company offers tertiary and quaternary care across key specialties, including cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and renal sciences. It also operates a diagnostic network through ManipalTRUtest and has expanded its footprint through acquisitions such as AMRI Hospital, Medica Synergie and Sahyadri Group.

Ahead of the IPO, Manipal Health Enterprises, on 28 July 2026, raised Rs 4,167.09 crore from anchor investors. The board allotted 7.06 crore shares at Rs 590 each to 133 anchor investors.

The firm reported a consolidated net profit of Rs 654.93 crore and sales of Rs 10,935.62 crore for the twelve months ended on 31 March 2026.

Powered by Capital Market - Live News